Cargando…
Remnant cholesterol and the risk of cardiovascular disease in type 2 diabetes: a nationwide longitudinal cohort study
BACKGROUND: Elevated remnant cholesterol (remnant-C) is considered a risk factor for cardiovascular disease (CVD); however, whether this notion applies to the East Asian population with type 2 diabetes (T2D) has not been established. This study investigated the association between remnant-C concentr...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9632127/ https://www.ncbi.nlm.nih.gov/pubmed/36324177 http://dx.doi.org/10.1186/s12933-022-01667-6 |
_version_ | 1784823964417130496 |
---|---|
author | Huh, Ji Hye Han, Kyung-do Cho, Yun Kyung Roh, Eun Kang, Jun Goo Lee, Seong Jin Ihm, Sung-Hee |
author_facet | Huh, Ji Hye Han, Kyung-do Cho, Yun Kyung Roh, Eun Kang, Jun Goo Lee, Seong Jin Ihm, Sung-Hee |
author_sort | Huh, Ji Hye |
collection | PubMed |
description | BACKGROUND: Elevated remnant cholesterol (remnant-C) is considered a risk factor for cardiovascular disease (CVD); however, whether this notion applies to the East Asian population with type 2 diabetes (T2D) has not been established. This study investigated the association between remnant-C concentrations and the risk of CVD in Korean patients with T2D. METHODS: By using the Korean National Health Insurance Service database, 1,956,452 patients with T2D and without atherosclerotic CVD who underwent regular health checks between 2009 and 2012 were included. Cox regression analyses were conducted to assess the association between remnant-C concentrations and incident CVD comprising myocardial infarction (MI) and ischemic stroke. RESULTS: In total, 50,120 (2.56%) cases of MI and 73,231 (3.74%) cases of ischemic strokes occurred during a median follow-up of 8.1 years. The adjusted hazard ratios for MI and stroke in the highest remnant-C quartile were 1.281 (95% confidence interval [CIs], 1.249–1.314) for MI and 1.22 (1.195–1.247) for ischemic stroke, compared to those in the lowest quartiles. The results were similar, based on stratified analysis by age, sex, use of statin or fibrate, and levels of other cholesterol. The increased risk of CVD in the highest remnant-C quartile was profound in patients who had a longer T2D duration. A remnant-C concentration ≥ 30 mg/dL differentiated patients who were at a higher risk of CVD, compared to patients with a lower concentrations, regardless of whether LDL-C levels were or were not on target at ≤ 100 mg/dL. CONCLUSION: In Korean patients with T2D, remnant-C was associated with CVD, independent of the LDL-C level or other conventional CVD risk factors. Our finding confirmed evidence of the causal role of remnant-C on CVD, as a residual risk of CVD, in East Asian patients with T2D. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12933-022-01667-6. |
format | Online Article Text |
id | pubmed-9632127 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-96321272022-11-04 Remnant cholesterol and the risk of cardiovascular disease in type 2 diabetes: a nationwide longitudinal cohort study Huh, Ji Hye Han, Kyung-do Cho, Yun Kyung Roh, Eun Kang, Jun Goo Lee, Seong Jin Ihm, Sung-Hee Cardiovasc Diabetol Research BACKGROUND: Elevated remnant cholesterol (remnant-C) is considered a risk factor for cardiovascular disease (CVD); however, whether this notion applies to the East Asian population with type 2 diabetes (T2D) has not been established. This study investigated the association between remnant-C concentrations and the risk of CVD in Korean patients with T2D. METHODS: By using the Korean National Health Insurance Service database, 1,956,452 patients with T2D and without atherosclerotic CVD who underwent regular health checks between 2009 and 2012 were included. Cox regression analyses were conducted to assess the association between remnant-C concentrations and incident CVD comprising myocardial infarction (MI) and ischemic stroke. RESULTS: In total, 50,120 (2.56%) cases of MI and 73,231 (3.74%) cases of ischemic strokes occurred during a median follow-up of 8.1 years. The adjusted hazard ratios for MI and stroke in the highest remnant-C quartile were 1.281 (95% confidence interval [CIs], 1.249–1.314) for MI and 1.22 (1.195–1.247) for ischemic stroke, compared to those in the lowest quartiles. The results were similar, based on stratified analysis by age, sex, use of statin or fibrate, and levels of other cholesterol. The increased risk of CVD in the highest remnant-C quartile was profound in patients who had a longer T2D duration. A remnant-C concentration ≥ 30 mg/dL differentiated patients who were at a higher risk of CVD, compared to patients with a lower concentrations, regardless of whether LDL-C levels were or were not on target at ≤ 100 mg/dL. CONCLUSION: In Korean patients with T2D, remnant-C was associated with CVD, independent of the LDL-C level or other conventional CVD risk factors. Our finding confirmed evidence of the causal role of remnant-C on CVD, as a residual risk of CVD, in East Asian patients with T2D. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12933-022-01667-6. BioMed Central 2022-11-02 /pmc/articles/PMC9632127/ /pubmed/36324177 http://dx.doi.org/10.1186/s12933-022-01667-6 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Huh, Ji Hye Han, Kyung-do Cho, Yun Kyung Roh, Eun Kang, Jun Goo Lee, Seong Jin Ihm, Sung-Hee Remnant cholesterol and the risk of cardiovascular disease in type 2 diabetes: a nationwide longitudinal cohort study |
title | Remnant cholesterol and the risk of cardiovascular disease in type 2 diabetes: a nationwide longitudinal cohort study |
title_full | Remnant cholesterol and the risk of cardiovascular disease in type 2 diabetes: a nationwide longitudinal cohort study |
title_fullStr | Remnant cholesterol and the risk of cardiovascular disease in type 2 diabetes: a nationwide longitudinal cohort study |
title_full_unstemmed | Remnant cholesterol and the risk of cardiovascular disease in type 2 diabetes: a nationwide longitudinal cohort study |
title_short | Remnant cholesterol and the risk of cardiovascular disease in type 2 diabetes: a nationwide longitudinal cohort study |
title_sort | remnant cholesterol and the risk of cardiovascular disease in type 2 diabetes: a nationwide longitudinal cohort study |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9632127/ https://www.ncbi.nlm.nih.gov/pubmed/36324177 http://dx.doi.org/10.1186/s12933-022-01667-6 |
work_keys_str_mv | AT huhjihye remnantcholesterolandtheriskofcardiovasculardiseaseintype2diabetesanationwidelongitudinalcohortstudy AT hankyungdo remnantcholesterolandtheriskofcardiovasculardiseaseintype2diabetesanationwidelongitudinalcohortstudy AT choyunkyung remnantcholesterolandtheriskofcardiovasculardiseaseintype2diabetesanationwidelongitudinalcohortstudy AT roheun remnantcholesterolandtheriskofcardiovasculardiseaseintype2diabetesanationwidelongitudinalcohortstudy AT kangjungoo remnantcholesterolandtheriskofcardiovasculardiseaseintype2diabetesanationwidelongitudinalcohortstudy AT leeseongjin remnantcholesterolandtheriskofcardiovasculardiseaseintype2diabetesanationwidelongitudinalcohortstudy AT ihmsunghee remnantcholesterolandtheriskofcardiovasculardiseaseintype2diabetesanationwidelongitudinalcohortstudy |